How much funding has C16 Biosciences raised?

C16 Biosciences has raised $28.5M in total funding, most recently a Grant round.

Who are C16 Biosciences's investors?

C16 Biosciences's investors include Y Combinator Continuity Fund, Bill & Melinda Gates Foundation, Breakthrough Energy Ventures, Elemental Impact, Waldencast, Future Tech Labs.

When was C16 Biosciences founded?

C16 Biosciences was founded in 2018.

Where is C16 Biosciences headquartered?

C16 Biosciences is headquartered in New York, New York, United States.

What industry is C16 Biosciences in?

C16 Biosciences operates in Biotech, Climate Tech, Healthcare, Sustainability.

How many employees does C16 Biosciences have?

C16 Biosciences has 11-50 employees.

C16 Biosciences

Next-gen ingredients to decarbonize consumer products, starting w/…

New York, United States · Founded 2018 · $28.5M raised

YC S18

Headquarters: New York, New York
Employees: 11–50
Founded: 2018
Business Model: B2B

Website: c16bio.com
Total Funding: $28.5M
Last Round: $4.5M GrantJan 2024
Rounds: 3

About

C16 Biosciences is decarbonizing consumer products supply chains by producing next-generation ingredients. The company's biomanufacturing platform produces better performing, more sustainable alternatives to oils and fats, and their first product is an alternative to palm oil. The company owns and operates Palmless™ alternative fats and oils.

Summary

C16 Biosciences is a Biotech company based in New York, United States, founded in 2018. It has raised $28.5M in total across 3 rounds, most recently a $4.5M Grant round in Jan 2024. Investors include Y Combinator Continuity Fund, Bill & Melinda Gates Foundation and Breakthrough Energy Ventures.